Veterinary Artificial Insemination Market Top Players, Analysis And Forecast Till 2030: Grand View Research Inc.

 Veterinary Artificial Insemination Market Growth & Trends

The global veterinary artificial insemination market size is expected to reach a valuation of USD 11.25 billion by 2030, expanding at 6.21% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The key factors driving the market growth include increasing consumption of animal protein, growing demand for livestock productivity, and adoption of sexed semen. In March 2023, Genetics Australia - the country’slargest artificial breeding supplier announced that it would merge with URUS - a leading player in the veterinary artificial insemination industry. This would provide Genetics Australiaaccess to global marketsin marketing Australian genetics.

The COVID-19 pandemic resulted in many challenges including dampened growth, decreased sales and marketing activities, supply chain hurdles, and delays in the delivery of AI services. The erratic and uncertain consumption patterns in several key markets exacerbated by sporadic lockdowns and logistical bottlenecks further increased the uncertainty in the market. The growth was also dampened by other factors such as the African Swine Fever. Genus, for instance, reported labor shortages, adverse impact on retail food service demand and meat packing capacity, and international logistics delays due to the pandemic. The company indicated that in the near-term, feed input costs, ASF, and COVID-19 implications would continue to exert pressure on the global porcine industry, particularly in China and Europe. In North America, the pandemic led to packing plant slowdowns during H1 of 2021.

To fulfill the continuously increasing demand for meat and dairy products, market players are expanding artificial insemination solutions to breed high-quality livestock and enhance production. For example, in August 2020, Cogent with AB Europe launched a novel sexed semen service for U.K. sheep producers. In September 2021, LIC- an agritech co-operative based in New Zealand launched a sexed semen lab in the country to meet the growing demand. This boosted the cooperative’s capabilities to artificially inseminate about 4.5 million cattle between the Spring mating season of September to December 2021. Developing regions such as Latin America are also contributing to the growth of the market for veterinary artificial insemination. For instance, Brazil, one of the major countries in the region has been adopting AI increasingly for the past decade. The country has also deployed Fixed-Time Artificial Insemination (FTAI) techniques to increase profitability and success rate.

Request a free sample copy or view report summary: Veterinary Artificial Insemination Market Report

Veterinary Artificial Insemination Market Report Highlights

• By animal type, the bovine segment held the largest share of about 40% of the market in 2022 owing to rising consumption of beef, milk, and dairy products
• By solutions, the services segment accounted for the largest revenue share of over 40% of the market in 2022. Artificial insemination service providers often offer genetic consultation services to help animal owners and breeders select appropriate sires with desirable traits for their breeding programs. Growing adoption of these services fuels segment growth.
• Artificial insemination (AI) offers a safe and regulated environment for breeding, lowering the possibility of mishaps or injuries that could happen during natural mating. Furthermore, AI gives breeders more control over the breeding process, ensuring that mating takes place under the best possible circumstances, and raises the likelihood of viable pregnancies
• In terms of distribution channels, the private segment accounted for the largest revenue share in 2022 and is expected to maintain its dominance throughout the forecast period
• Private veterinary clinics and reproductive service providers are an integral part of the distribution channel. They offer artificial insemination services to clients and may collaborate with manufacturers, suppliers, and distributors to source AI products. These clinics often maintain stocks of equipment, consumables, and semen, and perform AI procedures on-site or through mobile services
• North America dominated the market with a share of about 30% in 2022 while Latin America is anticipated to grow at the fastest rate of over 6% in the coming years. The high livestock population and increasing supportive initiatives by the public and private sectors are some of the key factors contributing to the market growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-veterinary-artificial-insemination-market

Veterinary Artificial Insemination Market Segmentation

Grand View Research has segmented the veterinary artificial insemination market based on solutions, animal type, distribution channel, and region:

Veterinary Artificial Insemination Solutions Outlook (Revenue, USD Million, 2018 - 2030)

• Equipment & Consumables
• Semen
  • Normal
  • Sexed
• Services

Veterinary Artificial Insemination Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

• Bovine
• Swine
• Ovine & Caprine
• Equine
• Other Animals

Veterinary Artificial Insemination Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Private
• Public

Veterinary Artificial Insemination Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • The U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East and Africa (MEA)
  • South Africa
  • Rest of MEA

List of Key Players in the Veterinary Artificial Insemination Market

• Genus
• URUS Group LP
• CRV
• SEMEX
• IMV Technologies
• Select Sires Inc.
• Swine Genetics International
• Shipley Swine Genetics
• Stallion AI Services Ltd
• STgenetics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.